Global X Genomics & Biotechnology ETF
GNOM
GNOM
64 hedge funds and large institutions have $121M invested in Global X Genomics & Biotechnology ETF in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $134M → $121M (-$13.3M)
61% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 28
Holders
64
Holding in Top 10
–
Calls
$30K
Puts
$1K
Top Buyers
| 1 | +$4.07M | |
| 2 | +$1.95M | |
| 3 | +$482K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
+$389K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$303K |
Top Sellers
| 1 | -$3.37M | |
| 2 | -$2.25M | |
| 3 | -$471K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$380K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$325K |